研究单位：[1]Beijing Chao Yang Hospital[2]The First Affiliated Hospital of Soochow University[3]CARsgen Therapeutics Co., Ltd.[4]Xinhua Hospital, Shanghai Jiao Tong University School of Medicine[5]Tianjin Medical University General Hospital[6]First Affiliated Hospital of Zhejiang University[7]Beijing Hospital[8]Shanghai Tongji Hospital, Tongji University School of Medicine[9]First Affiliated Hospital of Wenzhou Medical University[10]Xiangya Hospital of Central South University[11]Peking University People's Hospital[12]Qilu Hospital of Shandong University[13]Sun Yat-sen University[14]First Affiliated Hospital, Sun Yat-Sen University[15]The first affiliated hospital of bengbu medical college,Bengbu,Anhui,China[16]Beijing Chaoyang hospital,Beijing,Beijing,China,100000[17]Guangdong Provincial People's Hospital,Guangzhou,Guangdong,China[18]Sun Yat-sen University Cancer Centre,Guangzhou,Guangdong,China[19]The 2nd People's Hospital of Shenzhen,Shenzhen,Guangdong,China[20]Henan Cancer Hospital,Zhengzhou,Henan,China[21]Union Hospital Tongji Medical College Huazhong University of Science and Technology,Wuhan,Hubei,China[22]The Third Xiangya Hospital of Central South University,Changsha,Hunan,China[23]Xiangya Hospital Central South University,Changsha,Hunan,China[24]Affiliated Hospital of Nantong University,Nantong,Jiangsu,China[25]The First Affiliated Hospital Of Soochow University,Suzhou,Jiangsu,China,215006[26]Shengjing Hospital of China Medical University,Shenyang,Liaoning,China[27]Qilu Hospital of Shandong University,Jinan,Shandong,China[28]The first Affiliated Hospital, College of medicine, Zhejiang University,Hanzhou,Zhejiang,China[29]The first Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang,China[30]Beijing Boren Hospital,Beijing,China[31]Beijing Hospital,Beijing,China[32]Peking University People's Hospital,Beijing,China[33]Peking University Third Hospital,Beijing,China[34]Tongji Hospital of Tongji University,Shanghai,China[35]Xinhua Hospital Affiliated To Shanghai Jiaotong University School of Medicine,Shanghai,China[36]Tianjin Medical University General Hospital,Tianjin,China[37]Henan Provincial People's Hospital,Zhengzhou,China
This is an open-label, single arm study to evaluate the safety and tolerability of treatment with CT053 CAR-BCMA T in patients with relapsed and/or refractory multiple myeloma.
